Promega Corporation offers GloSensor Technology cell-based biosensor technology for real-time monitoring of cAMP kinetics. The non-lytic, live-cell GloSensor cAMP Assay is the first application of the patent-pending technology, which features a genetically-engineered form of firefly luciferase. The benefit to screeners and scientists alike will be more biologically relevant data captured directly from living cells.

cAMP is key signaling molecule for many G-protein coupled receptors. GloSensor cAMP Assay is the first bioluminescent cell-based biosensor for the direct, intracellular kinetic monitoring of cAMP, and ideally suited to HTS and uHTS application. Researchers simply combine cells, compounds and GloSensor cAMP Assay Reagent, providing a 'zero-step' assay potential.

Promega